Contraceptive afterwards of first non-prescription

Contraceptive afterwards of first non-prescription
0.75mg left alkyne promise progesterone (Norlevo) of France HRA Pharma Company ,Already become been granted the contraceptive afterwards of the non-prescribed medicine position in the first of a staple market. Also in the first contraceptive afterwards of promise progesterone of left alkyne used alone of European Union. Introduce on to the French market on May 30, and is granted non-prescribed medicine (OTC) for June 1 Position. HRA Pharma says, on some Asians and/or African market, Obtain OTC position. It is by Besins-Iscovesco Company in France (its first market) Sell, the price of about 55 francs (8.70 dollars) ,All of his expenses can't be compensated for the social insurance. Won the licence last November, but this company waited for the determination of its legal status before putting it on market. France recognizes each other the procedure can be regarded as and joined than member's country according to European Union, so already sent out and sold the application to some other countries. France is mainly the country of Catholicism, so confirm contraceptive OTC position is like wondrously after a thing. But HRA Pharma said that French authorities wanted, reduce the intersection of stream of people and number of times, it grants OTC to be for being apt to receive it in status. Studies have suggested, the earlier the administration is, the better the result is. In addition, HRA Pharma says, the reason Only include progestogen, so side effect want little uniting the intersection of hormone and products, some research reveal, use separately left the intersection of alkyne and the intersection of promise and progesterone unite than estrogen with progestogen In order to tolerate effectively and better. Contraceptive alkyne estrone and left alkyne promise progesterone (Tetragqnon) afterwards of Schering AG Company listed on France with January of this year The competition, the latter is called PC4 in other countries. Hshcering AG reason Responsibility issue but last OTC status. But HRA Pharma says Contraceptive afterwards not more specialized than the prescription more responsibility questions. France Schering AG Chairman Xavier Guille des Battes says, he is right OTC licence feel whether because surprised, at doctor prescription of having in contraceptive afterwards. He says at the news briefing: "If fix It is OTC, we will withdraw from the city it frequently " A lot of requirements Can but activity people for some time right with the intersection of OTC and supply Definite OTC status welcome. Encourage other countries to grant the contraceptive products OTC status afterwards too in approval of France.

|